These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34100041)

  • 1. The length of disulfide bond-containing linkages impacts the oral absorption and antitumor activity of paclitaxel prodrug-loaded nanoemulsions.
    Gao Y; Zuo S; Li L; Liu T; Dong F; Wang X; Zhang X; He Z; Zhai Y; Sun B; Sun J
    Nanoscale; 2021 Jun; 13(23):10536-10543. PubMed ID: 34100041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating a Lipophilic Disulfide-Bridged Linoleic Prodrug into a Self-Microemulsifying Drug Delivery System to Facilitate Oral Absorption of Paclitaxel.
    Zhang M; Guo C; Miao Y; He Z; Tian C; Sun J
    Mol Pharm; 2023 Jan; 20(1):461-472. PubMed ID: 36525349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
    Tam YT; Shin DH; Chen KE; Kwon GS
    J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles Containing High Loads of Paclitaxel-Silicate Prodrugs: Formulation, Drug Release, and Anticancer Efficacy.
    Han J; Michel AR; Lee HS; Kalscheuer S; Wohl A; Hoye TR; McCormick AV; Panyam J; Macosko CW
    Mol Pharm; 2015 Dec; 12(12):4329-35. PubMed ID: 26505116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of a paclitaxel-loaded cationic nanoemulsome and its biodistribution via direct intratumoral injection.
    Xu Y; Asghar S; Li H; Chen M; Su Z; Xu Y; Ping Q; Xiao Y
    Colloids Surf B Biointerfaces; 2016 Jun; 142():81-88. PubMed ID: 26938323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Well-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxel.
    Lv S; Tang Z; Zhang D; Song W; Li M; Lin J; Liu H; Chen X
    J Control Release; 2014 Nov; 194():220-7. PubMed ID: 25220162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic study of the covalent loading of paclitaxel via disulfide linkers for controlled drug release.
    Yuan L; Chen W; Hu J; Zhang JZ; Yang D
    Langmuir; 2013 Jan; 29(2):734-43. PubMed ID: 23252889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-responsive prodrug for improving oral bioavailability of paclitaxel through bile acid transporter-mediated pathway.
    Lu X; Wu H; Liang Y; Zhang Z; Lv H
    Int J Pharm; 2021 May; 600():120496. PubMed ID: 33746013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer.
    Kim JE; Park YJ
    Int J Nanomedicine; 2017; 12():645-658. PubMed ID: 28176896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and development of spirulina polysaccharide-loaded nanoemulsions with improved the antitumor effects of paclitaxel.
    Du M; Yang Z; Lu W; Wang B; Wang Q; Chen Z; Chen L; Han S; Cai T; Cai Y
    J Microencapsul; 2020 Sep; 37(6):403-412. PubMed ID: 32401077
    [No Abstract]   [Full Text] [Related]  

  • 12. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
    Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
    Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymerizable disulfide paclitaxel prodrug for controlled drug delivery.
    Ding Y; Chen W; Hu J; Du M; Yang D
    Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():386-90. PubMed ID: 25280719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Programmed Hydrolysis in Designing Paclitaxel Prodrug for Nanocarrier Assembly.
    Fu Q; Wang Y; Ma Y; Zhang D; Fallon JK; Yang X; Liu D; He Z; Liu F
    Sci Rep; 2015 Jul; 5():12023. PubMed ID: 26166066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
    Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
    Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability enhancement of paclitaxel via a novel oral drug delivery system: paclitaxel-loaded glycyrrhizic acid micelles.
    Yang FH; Zhang Q; Liang QY; Wang SQ; Zhao BX; Wang YT; Cai Y; Li GF
    Molecules; 2015 Mar; 20(3):4337-56. PubMed ID: 25756651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Biological Evaluation and Low-Toxic Formulation Development of Glycosylated Paclitaxel Prodrugs.
    Mao Y; Zhang Y; Luo Z; Zhan R; Xu H; Chen W; Huang H
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30563132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy.
    Sun B; Luo C; Yu H; Zhang X; Chen Q; Yang W; Wang M; Kan Q; Zhang H; Wang Y; He Z; Sun J
    Nano Lett; 2018 Jun; 18(6):3643-3650. PubMed ID: 29726685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo tailor-made protein corona of a prodrug-based nanoassembly fabricated by redox dual-sensitive paclitaxel prodrug for the superselective treatment of breast cancer.
    Zhang D; Yang J; Guan J; Yang B; Zhang S; Sun M; Yang R; Zhang T; Zhang R; Kan Q; Zhang H; He Z; Shang L; Sun J
    Biomater Sci; 2018 Aug; 6(9):2360-2374. PubMed ID: 30019051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel-Paclitaxel Prodrug Nanoassembly as a Versatile Nanoplatform for Combinational Cancer Therapy.
    Han X; Chen J; Jiang M; Zhang N; Na K; Luo C; Zhang R; Sun M; Lin G; Zhang R; Ma Y; Liu D; Wang Y
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33506-33513. PubMed ID: 27960378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.